|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 411/04 |
| (11) | Patento numeris | 2542551 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11713057.5 |
| Europos patento paraiškos padavimo data | 2011-02-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-01-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-08-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2011/050824 |
| Data | 2011-02-25 |
| (87) | Numeris | WO 2011/107920 |
| Data | 2011-09-09 |
| (30) | Numeris | Data | Šalis |
| DE04892010 | 2010-03-04 | IN |
| (72) |
KSHIRSAGAR, Prakash Bhimaji, IN
BHOGE, Satish Manohar, IN
RICHHARIYA, Santosh, IN
SINGH, Kaptan, IN
|
| (73) |
Ranbaxy Laboratories Limited,
Head Office: 12th Floor Devika Tower 06 Nehru Place New Delhi, Delhi 110019,
IN
|
| (54) | A PROCESS FOR STEREOSELECTIVE SYNTHESIS OF 5-FLUORO-1-(2R,5S)-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE |
| A PROCESS FOR STEREOSELECTIVE SYNTHESIS OF 5-FLUORO-1-(2R,5S)-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE |